Research Article
Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation
Figure 2
Hyaluromycin inhibited the migration of PDAC cell lines. After treatment with various concentrations (0–50 μM) of hyaluromycin, the migrated cells were counted on day 1. Hyaluromycin significantly inhibited the migration of BxPC-3 at 25 and 50 μM (25 μM: , 50 μM: ).